000 01097nam a2200313 a 4500
005 20250914102025.0
008 011129s2001 xxu 001 0 eng b
020 _a1582120064
_cRM401.40
039 9 _a200203071152
_bzainol
_c200111291241
_dafandi
_c200110101536
_dlinda
_y08-06-2001
_zrasida
060 _aWB39
090 _aWB39.A512a 2001 9
110 2 _aAmerican Pharmaceutical Association
245 0 4 _aThe American Pharmaceutical Association drug treatment protocols /
_ceditor, Daniel H. Albrant
246 3 0 _aDrug treatment protocols
250 _a2nd ed.
260 _aWashington,DC :
_bAmerican Pharmaceutical,
_c2001
300 _a487 p. ;
_c29 cm.
650 2 _aDrug Therapy
_xstandards
_vHandbooks
650 2 _aClinical Protocols
_vHandbooks
650 2 _aDecision Trees
_vHandbooks
700 1 _aAlbrant, Daniel H.
907 _a.b12887018
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWB39.A512a 2001 9
914 _avtls000300095
990 _aMAH
991 _aJabatan Farmasi, HUKM
998 _ad
_ah
_b2001-06-08
_cm
_da
_feng
_gxxu
_y0
_z.b12887018
999 _c289217
_d289217